title: Fungal infections of the central nervous system.
abstract: The epidemiology of invasive fungal infections in immunocompromised patients is rapidly changing. Several of the fungi have worldwide distribution. However, some have specific geographical distribution. Sinocranial aspergillosis, mostly described from countries with temperate climates, occurs mostly in otherwise immunocompetent individuals Most of the systemic fungal pathogens have been associated with central nervous system (CNS) involvement. The major advances in CNS fungal infections are in the pathobiology, new diagnostic tools, and new therapies. In spite of these developments, there is still considerable delay in the diagnosis of CNS fungal infection. CNS fungal infections are associated with considerable morbidity and mortality. To achieve good outcomes early diagnosis and early institution of appropriate therapies are the key issues.
authors.affiliation: Continental Institute of Neurosciences & Rehabilitation, Continental Hospitals, IT & Financial District, Gachibowli, Hyderabad, India. Electronic address: jmkmurthy@satyam.net.in.
authors.forename: J M K
authors.initials: JM
authors.lastname: Murthy
authors.affiliation: Department of Pathology, Nizam's Institute of Medical Sciences, Panjagutta, Hyderabad, India.
authors.forename: C
authors.initials: C
authors.lastname: Sundaram
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D015984:Causality; D020314:Central Nervous System Fungal Infections / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D059906:Neuroimaging / Q000379:methods; D019635:Neurosurgical Procedures
chemical_list: D000935:Antifungal Agents
keywords: Fungal infections of CNS; antifungal agents; aspergillosis; blastomycosis; candidiasis; coccidioidomycosis; cryptococcal meningitis; histoplasmosis; zygomycosis